ArticleIndian journal of anaesthesia2025
Comparison of i-gel®, Ambu® AuraGain™, Baska Mask, LMA® Protector™ for airway management of obese surgical patients - A randomised comparative study.
Article in Indian journal of anaesthesia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical performance of i-gel and i-gel Plus for airway management of obese patients: A prospective randomised controlled trial.Indian journal of anaesthesia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: A few trials have studied the use of supraglottic airway devices (SADs) for obese patients. This trial aimed to compare four SADs: I-gel, Ambu AuraGain, Baska mask, and Laryngeal Mask Airway (LMA) Protector for airway management of obese patients. Methods: This parallel-group, single-blind, comparative randomised study included 154 obese patients aged between 18 and 60 years who were planned for elective surgery. They were randomly allocated one of the above four SADs for airway management. Each group had 38 patients. The allocated SAD was inserted after induction of anaesthesia. oropharyngeal leak pressure (OLP) was the primary outcome. Data were analysed using analysis of variance, Kruskal-Wallis, or χ Results: Baseline data of the patients were comparable. Mean OLP was highest with the Baska mask and lowest with the LMA Protector [32.97 (standard deviation (SD): 1.30) (95% confidence interval (CI): 32.54, 33.40] vs 30.08 (SD: 1.51) (95% CI: 29.58, 30.58) cm H Conclusion: For obese patients undergoing elective surgery, the Baska mask has the highest OLP, but I-gel, Ambu AuraGain, and LMA Protector are also acceptable choices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.